Search Results - "Nielsen, Mette Bak"
-
1
Severe steroid refractory gastritis induced by Nivolumab: A case report
Published in World journal of gastroenterology : WJG (28-04-2020)“…Immune checkpoint inhibitors are widely used for treatment of many advanced malignancies. Lower gastrointestinal (GI) side effects, such as diarrhea and…”
Get full text
Journal Article -
2
Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon Cancer-May Cold Tumors Simply Be Too Hot?
Published in Frontiers in immunology (31-08-2021)“…Systemic inflammation measured by the acute-phase protein CRP associates with poor outcome across cancer types. In contrast, local tumor-associated…”
Get full text
Journal Article -
3
The presence of interferon affects the progression of non-alcoholic fatty liver disease
Published in Genes and immunity (01-08-2022)“…Inflammation and metabolic dysfunction are hallmarks of the progression of non-alcoholic fatty liver disease (NAFLD), which is the fastest-growing liver…”
Get full text
Journal Article -
4
Oncological results and morbidity following intended curative resection and free jejunal graft reconstruction of cervical esophageal cancer: a retrospective Danish consecutive cohort study
Published in Diseases of the esophagus (12-03-2022)“…Summary Background The role of surgery in treatment of locally advanced cervical esophageal cancer (CEC) remains debated. In the European and American…”
Get full text
Journal Article -
5
Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection
Published in Acta oncologica (01-12-2016)“…To evaluate the role of interstitial pulsed dose rate brachytherapy (PDR-BT) in multimodality treatment of locally advanced primary or recurrent rectal and…”
Get more information
Journal Article -
6
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
Published in Hepatology communications (01-04-2023)“…The macrophage activation marker soluble (s)CD163 is associated with disease severity and prognosis in patients with primary biliary cholangitis (PBC)…”
Get full text
Journal Article